ストックスクリーナーアプリを入手
269.83
2.72%
-7.54
プレマーケット:
266.00
-3.83
-1.42%
前日終値:
$277.37
開ける：
$279.695
24時間の取引高:
949.89K
Relative Volume:
0.62
時価総額：
$38.64B
収益：
$2.50B
当期純損益:
$-226.32M
株価収益率:
-164.41
EPS:
-1.6412
ネットキャッシュフロー:
$71.51M
1週間 パフォーマンス:
-4.26%
1か月 パフォーマンス:
+22.59%
6か月 パフォーマンス:
+16.68%
1年 パフォーマンス:
+81.83%
1日の値動き範囲:
$268.16
$282.00
1週間の範囲:
$261.63
$283.87
52週間の値動き範囲:
$131.81
$288.04
Natera Inc Stock (NTRA) Company Profile
Compare NTRA vs TMO, DHR, IDXX, A
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
269.83 | 38.64B | 2.50B | -226.32M | 71.51M | -1.6412 |
TMO
Thermo Fisher Scientific Inc
|
543.19 | 201.86B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
205.01 | 145.10B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
576.07 | 45.44B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
136.10 | 38.44B | 7.23B | 1.41B | 1.09B | 4.979 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-14 | 開始されました | William Blair | Outperform |
| 2026-01-07 | 開始されました | Citigroup | Buy |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-10-27 | アップグレード | BNP Paribas Exane | Underperform → Neutral |
| 2025-09-22 | 再開されました | Wells Fargo | Equal Weight |
| 2025-03-13 | 開始されました | RBC Capital Mkts | Outperform |
| 2025-01-23 | 開始されました | Barclays | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-04-08 | 再開されました | Craig Hallum | Buy |
| 2024-02-20 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2023-12-29 | 繰り返されました | BTIG Research | Buy |
| 2023-12-14 | 開始されました | Guggenheim | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-11-13 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-09-28 | 開始されました | Bernstein | Mkt Perform |
| 2023-07-05 | 再開されました | JP Morgan | Overweight |
| 2023-05-05 | 開始されました | UBS | Buy |
| 2023-01-18 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-08-25 | 開始されました | Credit Suisse | Outperform |
| 2022-04-25 | 開始されました | Stephens | Overweight |
| 2022-03-08 | 開始されました | Goldman | Buy |
| 2022-01-06 | 再開されました | Piper Sandler | Overweight |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-06-15 | 開始されました | Raymond James | Mkt Perform |
| 2021-05-25 | 開始されました | Wells Fargo | Overweight |
| 2021-01-28 | 開始されました | Truist | Buy |
| 2020-10-08 | 開始されました | BTIG Research | Buy |
| 2020-09-28 | 開始されました | Morgan Stanley | Overweight |
| 2020-09-17 | 開始されました | SVB Leerink | Outperform |
| 2020-06-10 | 再開されました | Piper Sandler | Overweight |
| 2020-05-07 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-10-05 | 開始されました | JP Morgan | Neutral |
| 2018-07-05 | 繰り返されました | Piper Jaffray | Overweight |
| 2017-08-07 | 繰り返されました | Morgan Stanley | Overweight |
| 2016-11-10 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-23 | 繰り返されました | The Benchmark Company | Buy |
| 2016-05-11 | 繰り返されました | The Benchmark Company | Buy |
| 2016-04-19 | 開始されました | The Benchmark Company | Buy |
| 2015-09-28 | アップグレード | Wedbush | Neutral → Outperform |
| 2015-08-14 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2015-08-04 | 開始されました | Robert W. Baird | Outperform |
| 2015-07-27 | 開始されました | Morgan Stanley | Equal-Weight |
| 2015-07-27 | 開始されました | Piper Jaffray | Overweight |
| 2015-07-27 | 開始されました | Wedbush | Neutral |
すべてを表示
Natera Inc (NTRA) 最新ニュース
Finalized MolDx LCD Includes Expanded Coverage for Natera’s Prospera™ Portfolio - Business Wire
The Bull Case For Natera (NTRA) Could Change Following New Signatera JAMA Oncology Evidence On MRD-Guided Chemotherapy - simplywall.st
Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks - Yahoo Finance
Billionaire Stanley Druckenmiller's Top Holding Isn't Nvidia. Instead, It's This Under-the-Radar Stock That Wall Street Loves. - The Motley Fool
What's Driving Natera's Recent Stock Action, and Why Are Insiders Selling - Kavout | AI
Form 4 Natera Inc For: 15 July By Investing.com - Investing.com Nigeria
Natera (NTRA) co-founder sells 3,150 shares under Rule 10b5-1 plan - Stock Titan
Natera co-founder Sheena Jonathan sells $836,898 in stock - Investing.com
Rowan Emma Chapman (NASDAQ: NTRA) files Form 144 to sell shares - Stock Titan
Form 144 Natera For: 15 July By Investing.com - Investing.com Canada
NTRA (NASDAQ: NTRA) holder plans sale of 1,500 common shares - Stock Titan
NATERA INC : TD COWEN RAISES TARGET PRICE TO $325 FROM $280 - Moomoo
NTRA Maintained by Canaccord Genuity -- Price Target Raised to $330 - GuruFocus
Enterprise value to EBITDA forward of Natera, Inc. – BX:NTRA - TradingView
Form 144 Natera For: 13 July By Investing.com - Investing.com Canada
[144] Natera, Inc. SEC Filing - Stock Titan
Enterprise value to EBITDA forward of Natera, Inc. – XETR:45E - TradingView
Did EU Class C Status for Signatera Reshape Natera’s (NTRA) Long-Term Diagnostics Strategy? - Yahoo Finance
What's Driving Natera's Recent Stock Action and Insider Selling - Kavout | AI
Is Natera (NTRA) Fully Valued As Signatera Wins EU IVDR Certification? - simplywall.st
Natera (NTRA) Secures EU Certification, Is The Upside Already Priced In? - Yahoo Finance
Why Natera (NTRA) Stock Is Down Today - Quiver Quantitative
Natera (NTRA) Signatera Data Shows Who Benefits From Chemotherapy After CRC Surgery - Yahoo Finance
NTRA's Signatera Gains EU IVDR Certification for Multiple Cancers - Yahoo Finance
Natera (NTRA) Stock Still Looks Expensive After A Very Large Run - Yahoo Finance
NTRA Maintained by Morgan Stanley -- Price Target Raised to $310 - GuruFocus
Morgan Stanley Maintains Natera(NTRA.US) With Buy Rating, Raises Target Price to $310 - Moomoo
Natera, Inc. Stock 12‑Month Price Target Raised to $272.19, Implies 1% Downside - TradingView
Natera Announces IVDR Certification for Signatera™ Across Multiple Cancers - 01net
How New Signatera Colorectal Data and Trial Deals Could Shape Natera’s (NTRA) Long-Term Narrative - simplywall.st
Natera’s Signatera receives EU IVDR certification for MRD testing By Investing.com - Investing.com Nigeria
Natera’s Signatera receives EU IVDR certification for MRD testing - Investing.com
Natera Receives EU IVDR Certification for Signatera - Moomoo
Natera (NTRA) Achieves Significant Milestone with Signatera IVDR Certification - GuruFocus
Natera's Insider Selling Spree: A Red Flag Amidst Robust Growth - Kavout | AI
Natera executive chairman Matthew Rabinowitz sells $280,000 in shares By Investing.com - Investing.com Nigeria
Natera executive chairman Matthew Rabinowitz sells $280,000 in shares - Investing.com
(NTRA) Volatility Zones as Tactical Triggers - Stock Traders Daily
Form 4 Natera Inc For: 8 July By Investing.com - Investing.com Nigeria
Natera (NTRA) executive chair’s spouse sells 1,000 shares in pre‑planned trade - Stock Titan
Form 4 Natera Inc For: 6 July By Investing.com - Investing.com India
Natera president Solomon Moshkevich sells $818,710 in stock - Investing.com UK
Natera chief legal officer Daniel Rabinowitz sells $4.57m stock - Investing.com
Natera chief legal officer Daniel Rabinowitz sells $4.57m stock By Investing.com - Investing.com Australia
Natera | 4: Statement of changes in beneficial ownership of securities-Director Rubin Eric H - Moomoo
Natera president Solomon Moshkevich sells $818,710 in stock By Investing.com - Investing.com Australia
Natera (NTRA) president sells 3,000 shares under Rule 10b5-1 trading plan - Stock Titan
Natera (NTRA) legal chief sells 16,800 shares under Rule 10b5-1 plan - Stock Titan
Form 144 NATERA For: 6 July By Investing.com - Investing.com South Africa
Natera Inc (NTRA) 財務データ
収益
当期純利益
現金流量
EPS
1.03%
大文字化:
|
ボリューム (24 時間):